CATALAYER NEWS
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
Source: CNBC Top · 2026-09-08
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.
MORE FROM CNBC TOP
Trump warns Tehran over Pickaxe Mountain activity; U.S.-Iran exchange attacks on ships near Hormuz
2026-09-10
'Saved the day': How China helped keep the lid on oil price surge as Iran war disrupted supplies
2026-09-10
World’s largest contract chipmaker TSMC sees August revenue surge over 53% to record high
2026-09-10
Coinbase CEO sees U.S. crypto regulation advancing regardless of Clarity Act vote
2026-09-10
An ECB rate hike is ‘all but certain’ — but investors divided on what comes next
2026-09-10
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets